Tech Company Financing Transactions

VisCardia Funding Round

VisCardia, operating out of Beaverton, secured $12.5 million from Kinetic Ventures and private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Kinetic Ventures (Lead Investor)

private investors (Michael Mirro)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
8770 SW Nimbus Ave.
Beaverton, OR 97008
Email Address
VisCardia was incorporated in 2015 dedicated to commercializing our novel proprietary failure therapy. VisCardia based in Portland, OR is developing a novel implantable device therapy for treating heart failure, a condition that afflicts 10 million patients in the U.S. and Europe.
VisCardia LinkedIn Company Profile
Social Media
VisCardia Company Twitter Account
Company News
VisCardia News
VisCardia on Facebook
VisCardia on YouTube

Management Team

Email & Social
Chief Executive Officer
Peter Bauer
  Peter Bauer LinkedIn Profile  Peter Bauer Twitter Account  Peter Bauer News  Peter Bauer on Facebook
Executive Vice President
Ed Chinchoy
  Ed Chinchoy LinkedIn Profile  Ed Chinchoy Twitter Account  Ed Chinchoy News  Ed Chinchoy on Facebook
VP - Regulatory Affairs
Gregg Harris
  Gregg Harris LinkedIn Profile  Gregg Harris Twitter Account  Gregg Harris News  Gregg Harris on Facebook



Browse more venture capital transactions:

Prev: 2/3/2017: Vividion Therapeutics venture capital transaction
Next: 2/3/2017: Scytl venture capital transaction


Share this article


About Our VC Transactions Data

We report on funding rounds that are announced publicly. VC investment data records reported here are derived from publicly available VC deal announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary